Development of daptomycin for gram-positive infections (Q33920377)

30 July 2017

1 reference

title

Development of daptomycin for gram-positive infections (English)

1 reference

30 July 2017

gram-positive bacteria

0 references

author name string

Tally FP

series ordinal

1

1 reference

PubMed ID

11020247

30 July 2017

DeBruin MF

series ordinal

2

1 reference

PubMed ID

11020247

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Journal of Antimicrobial Chemotherapy

30 July 2017

1 reference

30 July 2017

46

1 reference

30 July 2017

523-526

1 reference

30 July 2017

4

1 reference

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

30 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Daptomycin disrupts membrane potential in growing Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Investigation of the early killing of Staphylococcus aureus by daptomycin by using an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

In vitro postantibiotic effect of daptomycin (LY146032) against Enterococcus faecalis and methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Daptomycin (LY146032) for prevention and treatment of experimental aortic valve endocarditis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Comparison of the investigational drug, LY146032, with vancomycin in experimental pneumonia due to methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

LY146032 in a hamster model of Staphylococcus aureus pneumonia--effect on in vivo clearance and mortality and in vitro opsonophagocytic killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

Effect of protein binding of daptomycin on MIC and antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F46.4.523

21 January 2018

Identifiers

DOI

10.1093/JAC/46.4.523

1 reference

30 July 2017

1 reference

PubMed ID

11020247